Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell lines
Authors:
- Caroline GestCGCaroline Gest
- Ulrich JoimelUJUlrich Joimel
- Limin HuangLHLimin Huang
- Linda-Louise PritchardLPLinda-Louise Pritchard
- Alexandre PetitAPAlexandre Petit
- Charlène DulongCDCharlène Dulong
- Catherine BuquetCBCatherine Buquet
- Chao-Quan HuCHChao-Quan Hu
- Pezhman MirshahiPMPezhman Mirshahi
- Marc LaurentMLMarc Laurent
- Françoise Fauvel-LafèveFFFrançoise Fauvel-Lafève
- Lionel CazinLCLionel Cazin
Open Access
- 6 February 2013
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 13 (1) , 63
Abstract
Rho GTPases are involved in cellular functions relevant to cancer. The roles of RhoA and Rac1 have already been established. However, the role of Rac3 in cancer aggressiveness is less well understood.Keywords
This publication has 49 references indexed in Scilit:
- IL-8 Signaling Plays a Critical Role in the Epithelial–Mesenchymal Transition of Human Carcinoma CellsCancer Research, 2011
- 6‐Shogaol, an active constituent of ginger, inhibits breast cancer cell invasion by reducing matrix metalloproteinase‐9 expression via blockade of nuclear factor‐κB activationBritish Journal of Pharmacology, 2010
- Important role of integrins in the cancer biologyCancer and Metastasis Reviews, 2010
- Extracellular Matrix-Induced Gene Expression in Human Breast Cancer CellsMolecular Cancer Research, 2009
- Regulation of Actin Assembly Associated With Protrusion and Adhesion in Cell MigrationPhysiological Reviews, 2008
- Rac1 and Rac3 have opposing functions in cell adhesion and differentiation of neuronal cellsJournal of Cell Science, 2007
- Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinomaEuropean Journal of Surgical Oncology, 2006
- Anti-RhoA and Anti-RhoC siRNAs Inhibit the Proliferation and Invasiveness of MDA-MB-231 Breast Cancer Cells in Vitro and in VivoMolecular Therapy, 2005
- Expression of seven main Rho family members in gastric carcinomaBiochemical and Biophysical Research Communications, 2004
- Treatment of epigallocatechin‐3‐gallate inhibits matrix metalloproteinases‐2 and ‐9 via inhibition of activation of mitogen‐activated protein kinases, c‐jun and NF‐κB in human prostate carcinoma DU‐145 cellsThe Prostate, 2003